Sablich Kim has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a disposition of 2082 shares of Jazz Pharmaceuticals plc ($JAZZ) on June 05, 2023.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Sablich Kim | EVP, GM of U.S. | D | Ordinary Shares | 2082 | $129.73 | 28,478.0000 | 62,539,000 | 6.81% | 0.00% |
| March 8, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Sablich Kim | EVP, GM of U.S., Commercial Ma | S | Ordinary Shares | 1752 | $139.42 | 31,821.0000 | 62,539,000 | 5.22% | 0.00% |
| March 8, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Sablich Kim | EVP, GM of U.S., Commercial Ma | S | Ordinary Shares | 1261 | $140.19 | 30,560.0000 | 62,539,000 | 3.96% | 0.00% |
| March 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Sablich Kim | EVP, GM of U.S., Commercial Ma | A | Ordinary Shares | 10429 | $0.00 | 35,183.0000 | 62,539,000 | 42.13% | 0.02% |
| March 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Sablich Kim | EVP, GM of U.S., Commercial Ma | F | Ordinary Shares | 1610 | $142.78 | 33,573.0000 | 62,539,000 | 4.58% | 0.00% |